Answer
It is licensed for treating and preventing recurrent venous thromboembolism in children, but the formulation must be appropriate for the child's age and swallowing ability.
Sources for this answer
- Dabigatran etexilate 110 mg Hard Capsules — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.